Cambridge Investment Research Advisors Inc. trimmed its position in shares of AbbVie Inc. (NYSE:ABBV – Free Report) by 8.4% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 487,742 shares of the company’s stock after selling 44,986 shares during the period. […] Read this story